Quick Takeaways
- Khalid Islam has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $2,702,667.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Khalid Islam
- Location
- Morris Plains, NJ
- Summary
- The estimated net worth of Khalid Islam is at least $2,702,667 dollars as of 25 Jun 2025. Khalid Islam is the Director of FENNEC PHARMACEUTICALS INC. and owns shares of FENNEC PHARMACEUTICALS INC. (FENC) stock worth about $1.77M. Khalid Islam is the Director of Gain Therapeutics, Inc. and owns shares of Gain Therapeutics, Inc. (GANX) stock worth about $929.7K.
- Signature
- /s/ Khalid Islam
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Khalid Islam and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: FENNEC PHARMACEUTICALS INC. ($1,773,000).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Khalid Islam
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| FENC | FENNEC PHARMACEUTICALS INC. | Director | $1,773,000 | 03 Jun 2025 | ||
| GANX | Gain Therapeutics, Inc. | Director | $929,667 | 24 Jun 2025 | ||
| PCSA | Processa Pharmaceuticals, Inc. | Director | 31 Mar 2022 |
Insider Transactions Reported by Khalid Islam:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.